Olfactomedin 4 Suppresses Tumor Growth and Metastasis of Mouse Melanoma Cells through Downregulation of Integrin and MMP Genes

Molecules and Cells

Volumn 34, Issue 6, 2012, Pages 555-562

  Park, Key Sun ^a   Kim, Kee Kwang ^a,b   Piao, Zheng Hao ^a,c   Kim, Mi Kyung ^a   Lee, Hyun Jean ^a   Kim, Yong Chan ^a,d   Lee, Ki Sung ^e   Lee, Jeung Hoon ^f   Kim, Kyoon Eon ^a  

^a Chungnam National University   (South Korea)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c HANGZHOU NORMAL UNIVERSITY   (China)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^e PaiChai University   (South Korea)

^f Chungnam National University College of Medicine   (South Korea)

Author keywords

B16F10 cells; cancer; metastasis; OLFM4; tumor growth

Indexed keywords

ALPHA1 INTEGRIN; ALPHA6 INTEGRIN; GELATINASE B; GLYCOPROTEIN; INTEGRIN; OLFACTOMEDIN; SCLEROPROTEIN;

ANIMAL; ARTICLE; C57BL MOUSE; CELL SURVIVAL; DOWN REGULATION; EXPERIMENTAL MELANOMA; GENETICS; HUMAN; METABOLISM; METASTASIS; MOUSE; PATHOLOGY; TUMOR CELL CULTURE;

ANIMALS; CELL SURVIVAL; DOWN-REGULATION; EXTRACELLULAR MATRIX PROTEINS; GLYCOPROTEINS; HUMANS; INTEGRIN ALPHA1; INTEGRIN ALPHA6; INTEGRINS; MATRIX METALLOPROTEINASE 9; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; TUMOR CELLS, CULTURED;

EID: 85027955541     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-012-0251-7     Document Type: Article

References (28)

1. Bardou, M., Barkun, A., Martel, M., Effect of statin therapy on colorectal cancer. Gut 59 (2010), 1572–1585.
2. Chen, L., Li, H., Liu, W., Zhu, J., Zhao, X., Wright, E., Cao, L., Ding, I., Rodgers, G.P., Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1. Carcinogenesis 32 (2011), 986–994.
3. Cho, S.J., Kim, J.S., Kim, J.M., Lee, J.Y., Jung, H.C., Song, I.S., Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice. Int. J. Cancer 123 (2008), 951–957.
4. Coussens, L.M., Fingleton, B., Matrisian, L.M., Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295 (2002), 2387–2392.
5. Curran, S., Murray, G.I., Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur. J. Cancer 36 (2000), 1621–1630.
6. Egeblad, M., Werb, Z., New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2 (2002), 161–174.
7. Favero, G.M., Otuki, M.F, Oliveira, K.A., Bohatch, M.S. Jr, Borelli, P., Barros, F.E., Maria, D.A., Fernandes, D., Bydlowski, S.P., Simvastatin impairs murine melanoma growth. Lipids Health Dis, 9, 2010, 142.
8. Felding-Habermann, B., Integrin adhesion receptors in tumor metastasis. Clin. Exp. Metastasis 20 (2003), 203–213.
9. Grover, P.K., Hardingham, J.E., Cummins, A.G., Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis. Cancer Metastasis Rev 29 (2010), 761–775.
10. Hartstein, M.E., Grove, A.S. Jr., Woog, J.J., The role of the integrin family of adhesion molecules in the development of tumors metastatic to the orbit. Ophthal Plast Reconstr. Surg 13 (1997), 227–238.
11. Kidera, Y., Tsubaki, M., Yamazoe, Y., Shoji, K., Nakamura, H., Ogaki, M., Satou, T., Itoh, T., Isozaki, M., Kaneko, J., Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway. J. Exp. Clin. Cancer Res, 29, 2010, 127 et al.
12. Kim, K.K., Park, K.S., Song, S.B., Kim, K.E., Up regulation of GW112 Gene by NF kappaB promotes an antiapoptotic property in gastric cancer cells. Mol. Carcinog 49 (2010), 259–270.
13. Kobayashi, D., Koshida, S., Moriai, R., Tsuji, N., Watanabe, N., Olfactomedin 4 promotes S-phase transition in proliferation of pancreatic cancer cells. Cancer Sci 98 (2007), 334–340.
14. Koshida, S., Kobayashi, D., Moriai, R., Tsuji, N., Watanabe, N., Specific overexpression of OLFM4(GW112/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis. Cancer Sci 98 (2007), 315–320.
15. Liu, W., Chen, L., Zhu, J., Rodgers, G.P., The glycoprotein hGC-1 binds to cadherin and lectins. Exp. Cell Res 312 (2006), 1785–1797.
16. Liu, W., Zhu, J., Cao, L., Rodgers, G.P., Expression of hGC-1 is correlated with differentiation of gastric carcinoma. Histopathology 51 (2007), 157–165.
17. Liu, W., Liu, Y., Zhu, J., Wright, E., Ding, I., Rodgers, G.P., Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma. Clin. Cancer Res 14 (2008), 1041–1049.
18. Liu, W., Yan, M., Liu, Y., Wang, R., Li, C., Deng, C., Singh, A., Coleman, W.G. Jr., Rodgers, G.P., Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection. Proc. Natl. Acad. Sci. USA 107 (2010), 11056–11061.
19. Luo, Z., Zhang, Q., Zhao, Z., Li, B., Chen, J., Wang, Y., OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer. J. Cancer Res. Clin. Oncol 137 (2011), 1713–1720.
20. Moretti, S., Martini, L., Berti, E., Pinzi, C., Giannotti, B., Adhesion molecule profile and malignancy of melanocytic lesions. Melanoma Res 3 (1993), 235–239.
21. Munshi, H.G., Stack, M.S., Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev 25 (2006), 45–56.
22. Oue, N., Sentani, K., Noguchi, T., Ohara, S., Sakamoto, N., Hayashi, T., Anami, K., Motoshita, J., Ito, M., Tanaka, S., Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int. J. Cancer 125 (2009), 2383–2392 et al.
23. Park, S.J., Kim, Y.T., Jeon, Y.J., Antioxidant dieckol downregulates the Rac1/ROS signaling pathway and inhibits Wiskott-Aldrich syndrome protein (WASP)-family verprolin-homologous protein 2 (WAVE2)-mediated invasive migration of B16 mouse melanoma cells. Mol. Cells 33 (2012), 363–369.
24. Woodhouse, E.C., Chuaqui, R.F., Liotta, L.A., General mechanisms of metastasis. Cancer 80 (1997), 1529–1537.
25. Yu, L., He, M., Yang, Z., Chen, G., Li, M., Wang, L., Chen, S., Olfactomedin 4 is a marker for progression of cervical neoplasia. Int. J. Gynecol. Cancer 21 (2011), 367–372.
26. Yu, L., Wang, L., Chen, S., Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers. Neoplasma 58 (2011), 9–13.
27. Zhang, J., Liu, W.L., Tang, D.C., Chen, L., Wang, M., Pack, S.D., Zhuang, Z., Rodgers, G.P., Identification and characterization of a novel member of olfactomedin-related protein family, hGC-1, expressed during myeloid lineage development. Gene 283 (2002), 83–93.
28. Zhang, X., Huang, Q., Yang, Z., Li, Y., Li, C.Y., GW112, a novel antiapoptotic protein that promotes tumor growth. Cancer Res 64 (2004), 2474–2481.